Expression and immunogenicity of the Plasmodium falciparum circumsporozoite protein: the role of GPI signal sequence.

[1]  B. Berkhout,et al.  Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity. , 2006, The Journal of general virology.

[2]  K. Mansfield,et al.  Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity , 2006, Nature.

[3]  Hong-gang Yu,et al.  De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses. , 2006, Vaccine.

[4]  A. Folgori,et al.  A Novel Adenovirus Type 6 (Ad6)-Based Hepatitis C Virus Vector That Overcomes Preexisting Anti-Ad5 Immunity and Induces Potent and Broad Cellular Immune Responses in Rhesus Macaques , 2006, Journal of Virology.

[5]  F. Zavala,et al.  Protective and pathogenic roles of CD8+ T cells during malaria infection , 2006, Parasite immunology.

[6]  B. Berkhout,et al.  Immunogenicity and Protection of a Recombinant Human Adenovirus Serotype 35-Based Malaria Vaccine against Plasmodium yoelii in Mice , 2006, Infection and Immunity.

[7]  Wentao Gao,et al.  Broad cellular immunity with robust memory responses to simian immunodeficiency virus following serial vaccination with adenovirus 5- and 35-based vectors. , 2006, The Journal of general virology.

[8]  F. Ennis,et al.  Recombinant adenovirus vector vaccine induces stronger cytotoxic T-cell responses than recombinant vaccinia virus vector, plasmid DNA, or a combination of these. , 2005, Viral immunology.

[9]  Q. Bassat,et al.  Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial , 2005, The Lancet.

[10]  K. Mansfield,et al.  Immunogenicity of Recombinant Fiber-Chimeric Adenovirus Serotype 35 Vector-Based Vaccines in Mice and Rhesus Monkeys , 2005, Journal of Virology.

[11]  M. Lifton,et al.  Immunogenicity of Heterologous Prime-Boost Regimens Involving Recombinant Adenovirus Serotype 11 (Ad11) and Ad35 Vaccine Vectors in the Presence of Anti-Ad5 Immunity , 2005, Journal of Virology.

[12]  J. Mascola,et al.  Replication-Defective Adenovirus Serotype 5 Vectors Elicit Durable Cellular and Humoral Immune Responses in Nonhuman Primates , 2005, Journal of Virology.

[13]  U. Krzych,et al.  The dissection of CD8 T cells during liver-stage infection. , 2005, Current topics in microbiology and immunology.

[14]  B. Berkhout,et al.  Novel Replication-Incompetent Vector Derived from Adenovirus Type 11 (Ad11) for Vaccination and Gene Therapy: Low Seroprevalence and Non-Cross-Reactivity with Ad5 , 2004, Journal of Virology.

[15]  Inacio Mandomando,et al.  Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial , 2004, The Lancet.

[16]  A. V. van Kuilenburg,et al.  The novel histone deacetylase inhibitor BL1521 inhibits proliferation and induces apoptosis in neuroblastoma cells. , 2004, Biochemical pharmacology.

[17]  R. Gazzinelli,et al.  Enhanced protective immunity against malaria by vaccination with a recombinant adenovirus encoding the circumsporozoite protein of Plasmodium lacking the GPI-anchoring motif. , 2004, Vaccine.

[18]  B. Berkhout,et al.  Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector , 2004, AIDS.

[19]  S. Kostense,et al.  Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity1 , 2004, The Journal of Immunology.

[20]  A. Wåhlin,et al.  Human hematopoietic (CD34+) stem cells possess high-affinity receptors for adenovirus type 11p. , 2004, Virology.

[21]  A. Hill,et al.  A CD4+ T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease , 2004, Nature Medicine.

[22]  H. Whittle,et al.  Prevalence of Neutralizing Antibodies to Adenoviral Serotypes 5 and 35 in the Adult Populations of The Gambia, South Africa, and the United States , 2004, Clinical Diagnostic Laboratory Immunology.

[23]  J. Shiver,et al.  Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors. , 2004, Annual review of medicine.

[24]  R. Koup,et al.  Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates , 2003, Nature.

[25]  S. Kostense,et al.  Replication-Deficient Human Adenovirus Type 35 Vectors for Gene Transfer and Vaccination: Efficient Human Cell Infection and Bypass of Preexisting Adenovirus Immunity , 2003, Journal of Virology.

[26]  M. Kaleko,et al.  Development of adenovirus serotype 35 as a gene transfer vector. , 2003, Virology.

[27]  Sebastian Maurer-Stroh,et al.  Enzymes and auxiliary factors for GPI lipid anchor biosynthesis and post-translational transfer to proteins. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[28]  G. Cross,et al.  Mutational analysis of the variant surface glycoprotein GPI-anchor signal sequence in Trypanosoma brucei. , 2002, Journal of cell science.

[29]  S. High,et al.  Early Events in Glycosylphosphatidylinositol Anchor Addition , 2001, The Journal of Biological Chemistry.

[30]  W. Leitner,et al.  Removal of the circumsporozoite protein (CSP) glycosylphosphatidylinositol signal sequence from a CSP DNA vaccine enhances induction of CSP‐specific Th2 type immune responses and improvesprotection against malaria infection , 2001, European journal of immunology.

[31]  L. Guilherme,et al.  Immune responses to multiple antigen peptides containing T and B epitopes from Plasmodium falciparum circumsporozoite protein of Brazilian individuals naturally exposed to malaria , 2001, Parasite immunology.

[32]  Denis Hochstrasser,et al.  A Totally Synthetic Polyoxime Malaria Vaccine Containing Plasmodium falciparum B Cell and Universal T Cell Epitopes Elicits Immune Responses in Volunteers of Diverse HLA Types1 , 2001, The Journal of Immunology.

[33]  W. Hawley,et al.  Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children. , 1999, The American journal of tropical medicine and hygiene.

[34]  A. van der Eb,et al.  New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses. , 1998, Human gene therapy.

[35]  M. Aidoo,et al.  Cytotoxic T cell reactivity and HLA‐B35 binding of the variant Plasmodium falciparum circumsporozoite protein CD8+ CTL epitope in naturally exposed Kenyan adults , 1997, European journal of immunology.

[36]  James M. Wilson,et al.  Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria. , 1997, Journal of immunology.

[37]  R. Tolle,et al.  Recognition of synthetic 104-mer and 102-mer peptides corresponding to N- and C-terminal nonrepeat regions of the Plasmodium falciparum circumsporozoite protein by sera from human donors. , 1996, The American journal of tropical medicine and hygiene.

[38]  S Udenfriend,et al.  How glycosylphosphatidylinositol-anchored membrane proteins are made. , 1995, Annual review of biochemistry.

[39]  Mark C. Field,et al.  Retention and degradation of proteins containing an uncleaved glycosylphosphatidylinositol signal. , 1994, The Journal of biological chemistry.

[40]  I W Caras,et al.  Requirements for glycosylphosphatidylinositol attachment are similar but not identical in mammalian cells and parasitic protozoa , 1994, The Journal of cell biology.

[41]  S. Hoffman,et al.  Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites. , 1993, The American journal of tropical medicine and hygiene.

[42]  J. Bonifacino,et al.  Uncleaved signals for glycosylphosphatidylinositol anchoring cause retention of precursor proteins in the endoplasmic reticulum. , 1993, The Journal of biological chemistry.

[43]  M. Alpers,et al.  Natural antibody responses against the non-repeat-sequence-based B-cell epitopes of the Plasmodium falciparum circumsporozoite protein , 1993, Infection and immunity.

[44]  K. Kodukula,et al.  Evidence that the putative COOH-terminal signal transamidase involved in glycosylphosphatidylinositol protein synthesis is present in the endoplasmic reticulum. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[45]  I. Caras,et al.  Proteins containing an uncleaved signal for glycophosphatidylinositol membrane anchor attachment are retained in a post-ER compartment , 1992, The Journal of cell biology.

[46]  D. Stüber,et al.  Recognition of different domains of the Plasmodium falciparum CS protein by the sera of naturally infected individuals compared with those of sporozoite-immunized volunteers. , 1992, Journal of immunology.

[47]  T. Nutman,et al.  Naturally acquired CD8+ cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. , 1992, Journal of immunology.

[48]  A. Moreno,et al.  T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites. , 1992, Memorias do Instituto Oswaldo Cruz.

[49]  D. Herrington,et al.  Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals. , 1991, The American journal of tropical medicine and hygiene.

[50]  I W Caras,et al.  A nonfunctional sequence converted to a signal for glycophosphatidylinositol membrane anchor attachment , 1991, The Journal of cell biology.

[51]  J. Berzofsky,et al.  Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[52]  S. Hoffman,et al.  Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum. , 1986, The New England journal of medicine.

[53]  A Krishan,et al.  Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining , 1975, The Journal of cell biology.